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Mouse embryonic stem cells can differentiate in vitro into cells of the nervous system, neurons and glia. This differentiation mimics stages
observed in vivo, including the generation of primitive ectoderm and neurectoderm in embryoid body culture. We demonstrate here that
embryonic stem cell lines mutant for components of the Hedgehog signaling cascade are deficient at generating neurectoderm-containing
embryoid bodies. The embryoid bodies derived from mutant cells are also unable to respond to retinoic acid treatment by producing nestin-
positive neural stem cells, a response observed in cultures of heterozygous cells, and contain cores apparently arrested at the primitive ectoderm
stage. The mutant cultures are also deficient in their capacity to differentiate into mature neurons and glia. These data are consistent with a role
for Hedgehog signaling in generating neurectoderm capable of producing the appropriate neuronal and glial progenitors in ES cell culture.
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The prospect of using human embryonic stem (ES) cells
for transplantation therapies has heightened our interest in
identifying the parameters that direct the differentiation of
mouse ES cells into specific cell types. Mouse ES cells have
been an active area of investigation for over 20 years (Evans
and Kaufman, 1981; Martin, 1981). They derive from the
inner cell mass of the blastocyst and demonstrate the classic
properties of stem cells, the ability to both self-renew and
differentiate. Since their origin is the early embryo, they
have the capacity to differentiate into cell lineages repre-
sentative of all three primary germ layers, and this ability is
observed both in vitro and in vivo (Beddington and Rob-
ertson, 1989; Doetschman et al., 1985; Evans and Kaufman,
1981; Martin, 1981). Before protocols can be designed to0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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USA.provide a supply of specific progenitor cells for cell trans-
plantation therapies, the in vitro conditions that generate
these cell types must be defined.
ES cells grown in suspension culture aggregate to form
embryoid bodies, consisting of an outer layer of visceral
endoderm and an inner core of primitive ectoderm cells
(Grabel, 1992). This primitive ectoderm begins as a solid
core and subsequently forms a columnar epithelial layer
surrounding a cavity, analogous to the proamniotic cavity
in the embryo (Coucouvanis and Martin, 1995). Both BMP
and Hedgehog signaling have been proposed to play a role in
this cavitation process (Coucouvanis andMartin, 1999;Maye
et al., 2000). The core ectoderm cells provide the source of the
various differentiated embryonic cell types subsequently
observed in culture, including neurectoderm. This transition
can be optimized under certain embryoid body culture con-
ditions, including the addition of conditioned medium from
the HepG2 hepatocyte cell line (Rathjen et al., 2002) or
culture in neuro-basal medium (Wichterle et al., 2002).
Subsequent differentiation into the cells of the nervous
system, neurons and glia, can be observed in continued
suspension culture or after attachment culture under a variety
of conditions. One protocol includes treatment of embryoid
bodies with retinoic acid (Bain et al., 1995), which is key to
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bodies are subsequently plated on adhesive substrates. A
variety of neuronal subtypes appear in these cultures, includ-
ing excitatory and inhibitory neurons (Bain et al., 1995). It
remains unclear, however, how retinoic acid promotes the
formation of embryoid bodies that are more committed to
neuronal lineages. Recent observations using ES cells sug-
gest that continued expression of the transcription factor
Oct3/4, also key for maintaining undifferentiated ES stem
cells, is involved in directing differentiation towards a neu-
ronal fate (Shimozaki et al., 2003).
We provide evidence here that secreted Hedgehog signals
promote the differentiation of ES cells into neurectoderm.
Our previous studies demonstrated that mouse ES embryoid
bodies provide an in vitro model of Hedgehog signaling:
Indian hedgehog (Ihh), one of the three hedgehog genes in the
mouse, is expressed by the outer visceral endoderm layer, and
the inner ectoderm core responds to the secreted protein by
up-regulating the expression of conventional downstream
target genes in this pathway, such as Patched 1 (Ptch1) and
Gli1 (Becker et al., 1997; Maye et al., 2000). Hedgehog
signaling is mediated by the action of two membrane pro-
teins, Patched and Smoothened (Smo) (McMahon, 2000).
Hedgehog peptide binds to Patched, relieving its inhibitory
action on Smoothened, thereby allowing Smoothened to
mediate downstream action (Murone et al., 1999). A great
deal of evidence supports a role for Hedgehog signaling in the
patterning and differentiation of cells and tissues of the
nervous system. The notochord and floor plate are ventral
sources of Sonic hedgehog, (Shh), producing a ventral-to-
dorsal gradient (Briscoe and Ericson, 1999). This gradient
influences the fates of different cell types in the developing
spinal cord (Briscoe et al., 2000). For example, the differen-
tiation of motor neurons, which arise from the ventral neural
tube, requires higher concentrations of Shh than the differ-
entiation of interneurons, which arise dorsal to the motor
neurons (Briscoe and Ericson, 1999). Treatment of ES
embryoid bodies with Shh promotes the differentiation of
interneurons and motor neurons (Wichterle et al., 2002).
Recent analysis of Shh, Smo, and Gli3 single and double
mutants, as well as chimeric embryos including Smo/ cells
(Rallu et al., 2002; Wijgerde et al., 2002) supports a role for
Hedgehog signaling in establishing ventral identity in the
spinal cord and telencephalon, though additional signals may
be involved as well.
While most studies have focused on the role of Shh in
cell fate choice and patterning in the CNS, Shh can also
function as a mitogen, stimulating proliferation of precur-
sors for neurons and glia. Shh/ mice have a substantial
growth defect in the forebrain (Chiang et al., 1996). Treat-
ment of telencephalic explants with Shh promotes expan-
sion of nestin-positive ventral neuronal precursor cells
(Kohtz et al., 1998). Ectopic expression of Shh leads to
over-proliferation of CNS precursor cells (Rowitch et al.,
1999). In the cerebellum, Shh is produced in the Purkinje
cells, and acts as a mitogen for granule neuron progenitors(Wallace, 1999; Wechsler-Reya and Scott, 1999). This
observation provides an explanation for the occurrence of
medulloblastomas, cerebellar tumors, in mice heterozygous
for a mutation in the Ptch1 gene, since this mutation leads to
an increase in Hedgehog signaling (Goodrich et al., 1997).
Mutation of the human PTCH1 gene has also been impli-
cated in sporadic medulloblastomas (Goodrich and Scott,
1998). Localized expression of an activating mutation of the
mouse Smo gene in the dorsal mid- and hindbrain results in
extensive overgrowth as well as conversion to ventral fates
in these regions (Hynes et al., 2000). In addition, Shh
peptide promotes the proliferation of hippocampal-derived
neural progenitors both in vitro and in vivo (Lai et al.,
2003). These studies suggest that Hedgehog signaling
promotes the proliferation of either neural stem cells or a
more specialized progenitor cell type.
To define the roles of Hedgehog signaling in ES cell
neurectoderm differentiation, we have taken a loss-of-func-
tion approach, using pharmacological reagents, as well as
genetic mutation analysis. Our previous studies using
reagents that promote Protein Kinase A (PKA) activity and
thereby inhibit Hedgehog signaling, suggested a role for this
pathway in generating the single-cell layer epithelial ecto-
derm core (Maye et al., 2000). We demonstrate here that
embryoid bodies differentiating in the presence of the Hedge-
hog signaling inhibitor cyclopamine (Beachy et al., 1997;
Taipale et al., 2000) express substantially lower levels of
neurectoderm markers. Ihh-deficient and Smo-deficient ES
cells form embryoid bodies that display little cavitation and
express lower levels of neurectodermmarkers, in comparison
with embryoid bodies derived from heterozygous mutant ES
cells. Interpretation of experiments examining the expression
of early pluripotent lineage markers, including Oct3/4 and
FGF-5, is consistent with the conclusion that cores of
embryoid bodies formed from either the Ihh or Smo mutant
ES cells are arrested at the primitive ectoderm stage and
cannot differentiate into neurectoderm. Retinoic acid treat-
ment promotes the transition from primitive ectoderm to
neurectoderm in heterozygous, but not homozygous mutant
cultures, inducing expression of the neural stem cell marker
nestin. Consistent with the absence of neurectoderm in
mutant embryoid bodies, neuron outgrowth cultures derived
from the Ihh or Smo heterozygous ES cells demonstrate
ample differentiation of nestin-positive neural stem cells, as
well as mature neurons and glia, whereas homozygous
mutant cultures are severely lacking in these cell types.Materials and methods
ES cell culture
All ES cell lines were maintained on neo-resistant STO
fibroblast feeder layers in DMEM (Gibco) and 15% fetal calf
serum (Sigma or Atlanta Biologicals) in the presence of
recombinant LIF. Ihh null and heterozygous cell lines were
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null and heterozygous lines were the generous gift of Andy
McMahon (Wijgerde et al., 2002). Embryoid bodies were
formed by removing the stem cells from the feeder layer and
culturing them in suspension without LIF, in DMEM con-
taining 15% FCS (Atlanta Biologicals) (Doetschman et al.,
1985). For experiments involving treatment with cyclop-
amine and veratramine, 2 AM of these reagents was added to
the culture medium after 24 h in suspension, and thereafter
upon the addition of fresh medium. For these experiments,
D3, R1, and R1-Ptch1/lacZ ES cell lines were used.
b-galactosidase and H&E staining
h-galactosidase staining was carried out on intact ES R1
Ptch1+/ lacZ embryoid bodies as previously described
(Mendelsohn et al., 1991). Embryoid bodies were then
postfixed in 3.7% formaldehyde for 2 h at room tempera-
ture, dehydrated and paraffin embedded. H&E staining was
carried out on dewaxed paraffin sections according to
standard protocols.
In situ hybridization, immunocytochemistry, and RT-PCR
Whole mount in situ hybridization on embryoid bodies
was performed as described in Maye et al. (2000). RNA
extraction and conditions for RT-PCR and primers for
Ptch1, Ihh, HPRT and Shh were also as described in Maye
et al. (2000). Primers for Sox1, Sox2, Otx2, Rax, Six3, and
Foxd4 were as follows (those not referenced were designed
by us):Gene Sense Antisense Reference
Sox1 aatccc-ctctca-gacggtg ttgatg-cattttg-ggggtat MGI
(Freeman
et al., 1998)
Sox2 caacgg-cagctac-agcatga gggcca-tgtgcag-tctactg
Otx2 aggagc-tgagtcg-ccacctc gtagccc-agggag-ggatgca (Belaoussoff
et al., 1998)
Rax gagttgc-tgcgagc-cctgtgt ccgatg-ataggcg-ctgatgct
Six3 ccagca-tcaggcc-atcggcga ggccttg-gctatca-tacatcc
Foxd4 ctccac-cgcccag-tcctctaa gtgctcg-gaacttg-cggaggaImmunocytochemistry for nestin was performed on
paraffin sections as follows: After dewaxing and incuba-
tion in 100% EtOH, slides were incubated in 1% H2O2 in
MeOH for 10 min. After rinsing in water and then PBS,
slides were blocked at least 30 min in a buffer containing
5% normal goat serum in PBS plus 0.1% Triton X-100.
They were then incubated overnight at 4jC in anti-nestin
monoclonal antibody (DSHB, rat 401, see reference be-
low) at a dilution of 1/4 in blocking buffer. The next day,
after several rinses in PBS, they were incubated for 1.5 to
2 h in a peroxidase-conjugated anti-mouse secondary,
(Transduction Laboratories, 1/1000), and visualized with
DAB.Chimeric embryoid bodies
Embryoid bodies were grown as usual, but dishes were
seeded with both Smo/ ES cells, which express lacZ, and
wild type ES cells, which do not. In each experiment, cells
were mixed in proportions ranging from 25% to 75% Smo/
cells. However, since the Smo null cells grow more slowly as
embryoid bodies than wild type or heterozygous cells, the
final proportions of null cells in each dish were lower. There
was no apparent tendency for the null and wild type cells to
segregate into separate embryoid bodies. At the end of the
culture period, embryoid bodies were briefly fixed and
stained for beta galactosidase to identify the Smo/ cells,
and processed as described above.
Retinoic acid induction of neuronal differentiation, and
immunofluorescence
Neuronal differentiation was induced as described in Bain
et al. (1995). Briefly, embryoid bodies were grown for 4 days
without and then 4 days with 5 107 M retinoic acid. They
were then plated in the growthmedium (without retinoic acid)
onto permanox chamber slides coated with 10 Ag/ml laminin
(Sigma) and allowed to differentiate. After approximately 5
to 7 days, morphological differentiation toward neuronal
phenotypes was apparent in the heterozygous wells, at which
point the slides were fixed and immunocytochemistry was
performed according to standard protocols. Antibodies were
against nestin (Monoclonal antibody developed by Susan
Hockfield and obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the
NICHD and maintained by the University of Iowa, Dept. of
Biological Sciences, Iowa City, IA 52242, 1/4 dilution of
supernatant), TuJ1 (Research Diagnostics, 1/500), MAP2
(Sigma, 1/200), and RC2 (undiluted, gift of J. Crandall).
Staining was visualized using anti-mouse IgG or anti-mouse
IgM secondary antibodies, conjugated to Alexa 568 for red
and Alexa 488 for green fluorescence. Antibodies directed
against SSEA-1, developed by Davor Solter and obtained
from the Developmental Studies Hybridoma Bank developed
under the auspices of the NICHD and maintained by the
University of Iowa, Dept of Biological Sciences, Iowa City,
IA 52242, was used at 1/50 and visualized using anti-mouse
IgM Alexa (Molecular Probes). Antibodies directed against
Oct3/4 and FGF5 were obtained from Santa Cruz Biotech-
nology, Inc, used at dilutions of 1/40 and 1/20, respectively
and visualized using Alexa conjugated anti-rabbit IgG from
Molecular Probes.
Scoring of stained embryoid bodies
After immunostaining, the outgrowth region around the
embryoid bodies was scored on a scale of  to +++, where
 indicates the absence of nestin-positive cells, + indicates a
few nestin-positive cells, generally at the periphery of the
outgrowth, ++ indicates modest nestin staining and +++
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Fig. 1. RT-PCR and in situ hybridization analysis of neurectoderm markers in ES embryoid bodies. (A) RT-PCR demonstrates that Ptch1 is up-regulated as
embryoid bodies mature. Sox-2 is expressed in stem cells and all embryoid body stages. Otx-2 is not expressed by stem cells but is up-regulated in Day 4. Six-3
and FoxD-4 are not expressed in stem cells and are up-regulated in Day 8. Sox-1 and Rax/Rx are expressed in stem cells and slightly up-regulated in Day 8.
HPRT is shown as a control for equal loading of RNA. (B) In situ hybridization for most of these genes shows that they are expressed in the columnar ectoderm
of Day 11 embryoid bodies. Scale bar equals 100 Am.
P. Maye et al. / Developmental Biology 265 (2004) 276–290 279indicates extensive nestin staining originating at the edge of
the embryoid body and extending throughout the outgrowth
domain.
Photography and images
Slides were photographed using a Nikon E400 light
microscope equipped with a Spot camera (Diagnostic
Instruments), and processed using Adobe Photoshop.Results
Embryoid body core expresses ectoderm and neurectoderm
markers
When ES cells are placed into suspension culture, they
differentiate into embryoid bodies that contain an outer layer
of visceral endoderm surrounding an inner core of pluripo-
tential cells. This inner core subsequently differentiates into
primitive ectoderm and undergoes cavitation to form a
columnar epithelial layer (Coucouvanis and Martin, 1995),
which then gives rise to the multiple cell types, representative
of all three primary germ layers, observed subsequently in
culture (Doetschman et al., 1985). We have previously
demonstrated that by Days 5–7 the outer visceral endoderm
layer is a source of Ihh, while the core cells up-regulate Ptch1
expression, which indicates a Hedgehog response (Becker et
al., 1997; Maye et al., 2000). To characterize the cell type
present in the inner epithelial layer of ES embryoid bodies,
we used RT-PCR and in situ hybridization to examine the
spatial and temporal expression of a variety of ectoderm and
neurectoderm markers. Given the difficulty of obtainingquantitative information from RT-PCR data, experiments
shown reflect observations made in at least three separate
experiments. The up-regulation of Ptch1 demonstrates the
timing of the Hh response (Fig. 1A). Expression of Sox-2,
which in the embryo is first expressed in the morula and inner
cell mass (Avilion et al., 2003), then throughout the ectoderm
before becoming restricted to the anterior neural ectoderm, is
present both in undifferentiated stem cells and throughout the
time course of differentiation (Fig. 1A). Otx-2, a marker of
ectoderm and later anterior neurectoderm, (Ang et al., 1994)
is not detected in stem cells, but up-regulated by Day 4 (Fig.
1A). This gene is also expressed in the anterior visceral
endoderm (AVE) in the embryo, but in situ hybridization
analysis, shown below in Fig. 1B, indicates expression in
embryoid body cores. Sox-1 is expressed throughout the
anterior–posterior axis of the neural plate and neural tube
in dividing cells (Pevny et al., 1998; Uwanogho et al., 1995).
It is therefore somewhat surprising to observe expression of
Sox-1 in stem cells (Fig. 1A). This expression is likely not due
to high levels of spontaneous differentiation in the stem cell
sample, since it was observed in several experiments, but
rather reflects anomalous gene expression sometimes ob-
served in ES stem cells. Despite the apparent expression of
Sox-1 in stem cells, it is down-regulated by Day 4 and
subsequently up-regulated betweenDays 4 and 8 of embryoid
body culture. The anterior neurectoderm markers Six-3,
FoxD-4, and Rax/Rx (Kaestner et al., 1995; Oliver et al.,
1995; Furukawa et al., 1997) are all up-regulated between
Days 4 and 8 (Fig. 1A). In situ hybridization analysis for a
subset of these genes demonstrates that they are expressed
specifically in the core (Fig. 1B), although just 20–30% of
the embryoid bodies show expression of any of these
markers, suggesting that under these conditions only a subset
Fig. 2. Analysis of cyclopamine-treated Day 10 embryoid bodies. (A) Treatment of embryoid bodies with cyclopamine, but not with the control compound
veratramine, inhibits the expression of Ptch1-LacZ. Two micromolar cyclopamine or veratramine were added to embryoid body cultures after 24 h in
suspension and thereafter whenever the medium was changed. (B) RT-PCR analysis of RNA isolated from Day 10 embryoid bodies shows that cyclopamine,
but not veratramine, inhibits the expression of molecular markers for ectoderm. Two separate experiments are shown. (C) In situ hybridization for Ptch1, Otx-2
and Rax/Rx shows that expression of these genes is inhibited in embryoid bodies treated with cyclopamine, when compared to untreated controls. Scale bar
equals 100 Am.
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tent with observations made by others (Rathjen et al., 1999),
and demonstrate that at least a subpopulation of the embryoid
body cores can form neurectoderm-like cells from primitive
ectoderm precursors.
Cyclopamine inhibits Hedgehog signaling and the expression
of ectoderm and neurectoderm markers
Steroid alkaloids, such as cyclopamine, can be effective
inhibitors of Hedgehog signaling at relatively low concen-
trations (Cooper et al., 1998; Incardona et al., 1998). These
inhibitors appear to act at the level of Smo, the positive
membrane effector of Hedgehog signaling (Taipale et al.,
2000). Treatment of ES embryoid bodies with cyclop-
amine, but not the control compound veratramine (Beachy
et al., 1997), decreases Ptch1 expression in embryoid
bodies, as assayed by decreased lacZ staining in an ES
cell line that contains one copy of an insertion that
includes a lacZ gene, expressed under the control of the
Ptch1 promotor. (Fig. 2A). RT-PCR analysis of RNA
isolated from Day 10 embryoid bodies confirms this
observation, and indicates that cyclopamine treatment
inhibits accumulation of Ptch1 and gli1 (data not shown).
These observations demonstrate that cyclopamine treat-
ment inhibits the responses to Hedgehog signals, since
target genes are no longer up-regulated. Under these
conditions, we observe that the extent of ectoderm and
neurectoderm differentiation is also inhibited. Fig. 2Bshows RT-PCR analysis of RNA isolated from Day 10
embryoid bodies, which indicates that the expression of
molecular markers for ectoderm and neurectoderm line-
ages, Sox2, Otx-2, Six-3, FoxD-4, Sox1, and Rax/Rx is
inhibited by cyclopamine, but not veratramine treatment.
Note that the more definitive neurectoderm markers, such
as FoxD-4, are more severely affected. Fig. 2C shows in
situ hybridization analysis for Otx-2 and Rax/Rx expression
that also suggests these genes are down regulated with
cyclopamine treatment. Fig. 2C also shows that cyclop-
amine inhibits Ptch1 expression, further documenting the
successful inhibition of Hedgehog signaling. These data
suggest that Hedgehog signaling is required for neurecto-
derm differentiation in the embryoid body core.
ES cells mutant for components of the Hedgehog cascade
show decreased neurectoderm differentiation, but
comparative rates of proliferation and cell death are
difficult to obtain
To more definitively examine the role of Hedgehog
signaling in neurectoderm differentiation, we examined
the ability of Ihh/ and Smo/ ES cells to differentiate
into embryoid bodies. Fig. 3A shows that following 7 or
10 days in suspension culture, while embryoid bodies
formed from an Ihh heterozygous mutant cell line were
able to form a cavity surrounded by a columnar epithelial
ectoderm cell layer, homozygous mutant cells rarely
formed cavities or contained an organized columnar
Fig. 3. Analysis of ES embryoid bodies mutant for Ihh. (A) Embryoid bodies formed from Ihh+/ ES cells cavitate and form a columnar layer of ectoderm,
while those from Ihh/ ES cell lines do not. H&E stained paraffin sections of embryoid bodies at Days 7 and 10 are shown. (B) RT-PCR analysis of RNA
isolated from Day 10 embryoid bodies derived from two heterozygous and one homozygous mutant ES cell lines shows that, as expected, the Ihh/ embryoid
bodies do not express Ihh. Expression of Otx-2 and Sox-2 is slightly reduced in the Ihh/ cell line, and expression of Sox-1, FoxD4, and Rax/Rx is almost
absent.
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of RNA isolated from Day 10 embryoid bodies, that, as
expected, the mutant cell line does not express Ihh
mRNA. RT-PCR data are shown for two heterozygous
(14 and 37) and one homozygous cell line (14–61).
Previous time course analysis shows that Shh mRNA is
expressed in all of these cell lines beginning at Day 10, a
few days after the up-regulation of Ihh expression (Byrd
et al., 2002). Fig. 3B confirms this observation and also
demonstrates that the expression levels of Sox1, FoxD4,
Rax/Rx, and to a lesser extent Otx2 and Sox2, are
decreased in homozygous mutant cultures in comparison
to the heterozygous mutant cultures. The decrease in the
level of expression of these markers in the Ihh/ cultures
is not as marked as observed with cyclopamine treatment.
This discrepancy may be due to the presence of residual
levels of Shh in the mutant cultures (Byrd et al., 2002)
that could support neurectoderm differentiation.
We therefore examined ectoderm and neurectoderm
differentiation in embryoid bodies derived from Smo/
ES cells. Fig. 4A shows that, like the Ihh homozygous
mutant cultures, the Smo-deficient cells form embryoid
bodies that fail to cavitate or form an organized columnar
epithelial layer. Fig. 4B shows that Sox2 and Otx2,
expressed in primitive ectoderm as well as neurectoderm,
are slightly decreased, while the neurectoderm markers
Six3, FoxD4, Sox1, and Rax/Rx are barely detectable in
the homozygous mutant cultures relative to the heterozy-
gous mutant cultures. Data are presented for two hetero-
zygous lines, 37 and 41, and two homozygous mutant
lines, 24 and 44. These RT-PCR data show more striking
deficits in the expression of ectoderm and neurectodermmarkers in the Smo/ mutant embryoid bodies compared
to Ihh/ mutant embryoid bodies, most likely due to the
absence of all Hedgehog responses in these cells. In situ
hybridization analysis for Ptch1, Otx2, and Rax/Rx sup-
ports the conclusion that the Smo homozygous mutant cells
are unable to generate neurectoderm (Fig. 4C). Note that
although data are frequently shown for only one cell type
for each genotype, an additional cell line for each genotype
behaved similarly in all experiments.
The observation that there is decreased neurectoderm
differentiation under conditions that compromise Hedgehog
signaling would be consistent with reduced levels of
proliferation of appropriate progenitor cells in embryoid
bodies cores. This conclusion is supported by the observa-
tion that embryoid bodies derived from either Ihh or Smo
mutant ES cells appear smaller than those derived from
heterozygous or wild type cells. To determine if the
decrease or absence of Hedgehog signaling results in
decreased proliferation of the stem cell or ectoderm core
cells, we attempted to measure rates of proliferation by a
variety of methods, including BrdU labeling as well as
expression of phospho-histone H3, a marker for mitotic
cells. We first established that the stem cells proliferated at
comparable rates regardless of their genotype (data not
shown). We were consistently unable to see a statistically
significant difference in proliferation levels between het-
erozygous and mutant embryoid body cultures at Days 4, 7,
or 9. We were also unable to see a statistically significant
difference in the level of programmed cell death, as assayed
by TUNEL staining. This analysis, however, is confounded
by cavitation occurring in the cultures of heterozygous
cells, but not homozygous mutant cells, beginning as early
Fig. 4. Analysis of ES embryoid bodies mutant for Smo. (A) Embryoid bodies formed from Smo+/ cells cavitate and form a columnar layer of ectoderm, while
those from Smo/ ES cell lines do not. H&E stained paraffin sections of embryoid bodies at Days 7 and 10 are shown. Scale bar equals 300 Am. (B) RT-PCR
analysis of RNA isolated from Day 10 embryoid bodies derived from two heterozygous and two homozygous mutant ES cell lines shows that Sox-2 and Otx-2
are slightly down-regulated in the Smo/ embryoid bodies, and that Six-3, FoxD4, Sox-1, and Rax/Rx are severely down-regulated. HPRT is shown as a
control for equal loading of RNA. (C) In situ hybridization analysis shows that Ptch1, Otx-2 and Rax/Rx are significantly down-regulated in Smo/ embryoid
bodies, compared to heterozygous controls. Six-micrometer paraffin sections of Day 10 embryoid bodies are shown. Scale bar equals 100 Am.
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levels of cell death in the mutant cultures may therefore be
obscured by the apoptotic process that produces the cavities
in the heterozygous cultures (Coucouvanis and Martin,
1995). We were therefore unable to determine if the
absence of neurectoderm in mutant cultures was due to a
lack of differentiation, or could, at least in part, be
attributed to a defect in progenitor proliferation.
Chimeric embryoid body differentiation supports a role for
Hedgehog signaling in ectoderm layer maturation
Experiments analyzing the behavior of ES cells carry-
ing mutations for Hedgehog cascade genes suggest thatembryoid body ectoderm differentiates only after receiving
an Ihh signal from the outer visceral endoderm layer. To
test this we next asked whether Smo-deficient ES cells
could contribute to a cavitated inner ectoderm layer in
embryoid bodies formed from a mixture of wild type and
mutant cells. We mixed Smo mutant ES and wild type or
heterozygous cell lines. The Smo/ cells were derived
from a ROSA mouse strain that constitutively expresses
lacZ in all cells, whereas other cell lines used were not
lacZ-expressing. Cells were mixed at various ratios of
mutant/wild type, ranging from 25 to 75% mutant cells.
Since the homozygous Smo mutant cells appear to grow
more slowly than the heterozygous or wild type cell lines
in the mixture, despite our inability to definitively estab-
Fig. 5. Chimeric embryoid bodies. Embryoid bodies were formed by
mixing Smo/ and Smo+/ ES cells at a ratio of 1:1. After 9 days in
culture, embryoid bodies were fixed and Smo/ cells identified by h-
galactosidase staining, followed by embedding, sectioning, and H&E
staining. Heterozygous cells have formed a layer of columnar ectoderm
(arrows), but Smo/ cells (blue) were never observed to do this. Smo/
cells did, however, readily contribute to the outer layer of endoderm and
display the characteristic columnar morphology of visceral endoderm cells
(arrowhead).
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experiment was always lower than at the start of the
experiment. Fig. 5 demonstrates our observation that the
Smo/ mutant cells, even when present in abundance,
did not integrate into a cavitated mature ectoderm layer
(see arrows in Fig. 5). When localized to the core, these
cells were part of a disorganized solid mass of cells. In
contrast, mutant cells were readily observed in the outer
endoderm layer and appear to be capable of differentiating
into visceral endoderm, based upon their characteristic
morphology (see arrowhead in Fig. 5). These observations
support the importance of a Hedgehog response in the
embryoid body core for ectoderm differentiation and
maturation.
Characterization of the core of embryoid bodies deficient in
Hedgehog signaling
The ES embryoid body in vitro system nicely mimics the
in vivo progression of inner cell mass through primitive
ectoderm, to neurectoderm. We have already demonstrated
that the cores of embryoid bodies derived from Ihh or Smo
mutant cells do not express neurectoderm markers. The
continued expression of Otx2 and Sox2, expressed in
primitive ectoderm as well as neurectoderm but not in stem
cells, suggests that embryoid bodies derived from mutant ES
cells are able to differentiate into primitive ectoderm. To
definitively determine if these cores are arrested at the
equivalent of the inner cell mass stage, or are able to
progress to the primitive ectoderm stage, we examined the
expression of three markers of early embryonic cell typesusing immunohistochemistry. SSEA-1 antigen is an epitope
expressed by inner cell mass and ES stem cells as well as by
primitive ectoderm, and down-regulated in neurectoderm
(Fox et al., 1981). Oct 3/4 is a POU-family transcription
factor critical for early pluripotent cell lineages, expressed
by inner cell mass and ES cells as well as by primitive
ectoderm, and also down-regulated upon differentiation into
neurectoderm (Rosner et al., 1990; Scholer et al., 1990;
Minucci et al., 1996). FGF5 is not expressed by inner cell
mass or ES cells, but is up-regulated in primitive ectoderm
and then down-regulated once neurectoderm forms (Hebert
et al., 1991; Pelton et al., 2002).
Fig. 6A (minus RA panels on the left ) shows that at
Day 9, embryoid bodies derived from either Ihh+/ or
Smo+/ ES cells express SSEA-1 in columnar epithelial
cores. In these cultures around 50% of the embryoid
bodies exhibit strong staining in a cavitated columnar
epithelial core layer. The rest of the embryoid bodies
show staining in a solid core that has not cavitated. In
contrast, virtually all of the core staining seen in embry-
oid bodies derived from mutant ES cells shows SSEA-1
cell expression in a solid core. Similarly, Oct 3/4 expres-
sion is predominantly seen in cavitated core cells, or
alternatively in a solid core in heterozygous cultures,
whereas the mutant cultures demonstrate expression ex-
clusively in solid cores (Fig. 6B). Since the expression of
these markers does not allow us to distinguish between a
stem cell or primitive ectoderm identity for the core, we
examined FGF5 expression, observed in primitive ecto-
derm but not in inner cell mass or stem cells (Pelton et
al., 2002). Fig. 6C shows that embryoid bodies derived
from mutant as well as heterozygous cell lines express
FGF5, both in the matrix-rich region between the core
and extraembryonic endoderm layer, and between core
cells. Concentration of FGF5 in extracellular matrices has
been previously observed (Kitaoka et al., 1997). These
data suggest that the Ihh and Smo mutant cell lines can
form primitive ectoderm, but cannot progress to cavitate
or differentiate into neurectoderm.
The role of retinoic acid in promoting the primitive
ectoderm to neurectoderm transition
To verify that the absence of Hedgehog signaling results in
embryoid body cores stalled at the primitive ectoderm stage,
we examined the ability of the mutant cultures to produce
neurectoderm derivatives, neurons and glia. To promote
neuronal differentiation, we turned to a previously published
protocol that grows embryoid bodies for 4 days suspension
culture without, followed by 4 days suspension culture with
retinoic acid (Bain et al., 1995). Aggregates are then plated on
adhesive substrates to promote the differentiation of neuronal
derivatives (see Materials and methods for details). Before
examining the extent of neuronal differentiation, we com-
pared the extent of differentiation in untreated and retinoic
acid-treated embryoid bodies at the end of 8 days in suspen-
Fig. 6. SSEA-1, Oct 3/4, and FGF5 expression in untreated and retinoic acid-treated embryoid bodies. Embryoid bodies derived from Ihh+/, Ihh/, Smo+/,
or Smo/ ES cells were grown in absence or presence of retinoic acid (RA) as described in Materials and methods. After 9 days embryoid bodies were fixed
and paraffin sections analyzed by immunocytochemistry for the expression of (A) SSEA-1; (B) Oct 3/4; or (C) FGF5.
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formed from heterozygous Ihh or Smo cell lines do not
express nestin, an intermediate filament protein expressed
in neural stem cells and a few other cell types (Lendahl et al.,
1990; Mokry and Nemecek, 1998). However, when these
embryoid bodies are treated with retinoic acid to promote the
subsequent generation of neurons following culture on ad-
herent substrates (Bain et al., 1995), nestin expression is
dramatically up-regulated in the ectoderm layer. The ability
of the treated embryoid bodies to produce nestin-positive
cells suggests that retinoic acid has promoted a primitiveectoderm-to-neurectoderm transition. This conclusion is sup-
ported by the observation that retinoic acid treatment of these
cell lines also increases the level of expression of Sox1, an
early neuroepithelial marker present throughout the anterior–
posterior axis of the neural tube based upon RT-PCR analysis
(Figs. 7C and D). Additional support comes from the obser-
vation that treatment of heterozygous cultures with retinoic
acid decreases the level of expression of SSEA-1 and Oct 3/4,
two markers that are expressed in ectoderm and down-
regulated upon formation of the neural tube (Fig. 6). Low
levels of SSEA-1 expression remain detectible in the treated
Fig. 7. Nestin staining and neurectoderm marker expression in retinoic acid-treated Day 9 embryoid bodies. (A) Embryoid bodies formed from Ihh+/ and Ihh/
ES cells were grown with and without retinoic acid. Paraffin sections were stained with an anti-nestin antibody and counterstained with eosin. Ihh+/ embryoid
bodies express nestin in response to retinoic acid treatment, while Ihh/ embryoid bodies do not. (B) Embryoid bodies formed from Smo+/ and Smo/ ES
cells were grown with and without retinoic acid. Paraffin sections were stained with an anti-nestin antibody and counterstained with eosin. Smo+/ embryoid
bodies express nestin in response to retinoic acid treatment, while Smo/ embryoid bodies do not. RT-PCR analysis of RNA isolated from Day 9 Ihh+/ and
Ihh/ embryoid bodies (C), or Smo+/ and Smo/ embryoid bodies (D), either untreated or treated with retinoic acid was performed for genes shown. The
results of two separate experiments are shown. For both heterozygous cell lines, expression of Sox1 is increased by retinoic acid treatment, whereas Otx2 and
FoxD4 expression was inhibited by this treatment.HPRT is shown as a control for equal loading of RNA. Homozygous mutant cell lines display decreased levels
of these markers relative to heterozygous cell lines, and retinoic acid still appears to modestly increase levels of Sox1.
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Fig. 6), reminiscent of the observation in the embryo of
retained luminal surface staining of the neural tube (Fox et al.,
1981). Consistent with the demonstrated caudalizing effect of
retinoic acid on the developing CNS (Liu et al., 2001;
Simeone et al., 1995), the expression of the rostral-specific
markers Otx2, FoxD4, and Rax is inhibited by retinoic acid
treatment (Figs. 7C and D).
In contrast, embryoid bodies derived from the homozy-
gous mutant Ihh or Smo cell lines fail to express nestin
upon retinoic acid treatment (Figs. 7A and B). RT-PCR
analysis demonstrates that residual levels of expression of
the anterior-specific marker Otx2 are inhibited by retinoic
acid (Figs. 7C and D). Retinoic acid treatment also
decreases the level of expression of both SSEA-1 and Oct
3/4, and to a lesser extent FGF5, in embryoid bodies
derived from mutant cells (Fig. 6), suggesting that down-
regulation of these markers is not sufficient to promote
neurectoderm differentiation. These data suggest that in the
absence of Hedgehog signaling, retinoic acid is unable to
induce a transition from primitive ectoderm to neurecto-derm, despite the down-regulation of certain primitive
ectoderm markers.
ES cells carrying homozygous mutations in Hedgehog
signaling components show impaired capacity to
differentiate into neurons
We next tested the ability of these mutant ES cell lines to
form neuronal cell types. Embryoid bodies after 8 days of
suspension culture using the retinoic acid protocol were
plated on laminin-coated substrates and analyzed 5–8 days
later for the expression of neuronal markers. Data are
shown for only one cell line of both of the Smo genotypes,
but similar results were obtained with an additional cell line
of each of the Smo genotypes as well as with the Ihh+/ and
Ihh/ cell lines. In addition, three wild type cell lines
behaved similarly to the heterozygous cultures. Fig. 8A
quantifies the relative expression of nestin positive cells in
Smo heterozygous versus homozygous mutant cultures. The
outgrowth region around the embryoid bodies was scored
on a relative scale of  to +++, where  indicates the
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cells, frequently found at the periphery of the outgrowth,
++ modest nestin staining and +++ extensive nestin positive
staining originating at the edge of the embryoid body and
extending throughout the outgrowth domain. The cultures
of heterozygous mutant cells display extensive nestin-stain-
ing, with approximately 85% of the outgrowths containing
nestin positive cells, and over 25% displaying extensive
staining (Fig. 8A). In contrast, over 55% of the homozy-
gous mutant outgrowths have no nestin positive cells, and
no outgrowths display extensive nestin staining (Fig. 8A).
The predominant nestin-positive cell in the homozygous
mutant cultures is a large flattened cell found at the
periphery of the outgrowth. Previous reports have estab-
lished that nestin is expressed in muscle precursors and
epithelial cells, as well as in neural stem cells (Lendahl et
al., 1990; Mokry and Nemecek, 1998). Our observation that
the peripheral nestin-positive cells express a-smooth mus-
cle actin (data not shown) is consistent with their identifi-
cation as muscle precursor cells and not neural stem cells.
The conclusion that these cells may not be neural stem
cells, but another nestin-positive cell type, is supported by
the observation described further below that the homozy-
gous mutant cultures never generate cells with a neuronal
phenotype that express either a h-tubulin isoform recog-
nized by the TuJ1 antibody and expressed in neuronal
precursors and immature post-mitotic neurons (Menezes
and Luskin, 1994), or MAP2, a microtubule-associating
protein expressed in differentiating and mature neurons
(Caceres et al., 1984).
TuJ1-positive cells with neuronal morphology are ob-
served only in the heterozygous mutant cell line, whereas
rare TuJ1-positive cells in the Smo/ cultures do not have
this morphology. The heterozygous but not homozygous
cultures express MAP2 and exhibit long processes, sugges-
tive of neurons (Fig. 8B). In addition, we observed elon-
gated cells that are closely aligned (see arrows) with a
morphology reminiscent of radial glia. These cells stained
positively using an antibody directed against the radial glial
marker RC2 (Misson et al., 1988) indicating that they may
correspond to a glial cell type. Often these RC2-positive
cells were associated with TuJ1-positive cells (Fig. 8B).
Taken together, these data suggest that the Hedgehog
signaling pathway promotes the differentiation of multiple
neural cell types from ES cells.Fig. 8. Expression of neuronal markers in Smo+/ and Smo/ cultures. (A) Embry
staining (as described in Materials and methods). Over half the Smo+/ embryoid b
almost none of the Smo/ embryoid bodies did. (B) Retinoic-acid-treated emb
laminin-coated chamber slides, allowed to grow for several days, and then fixed
extensive nestin staining of Smo+/ cultures on the left, and on the right typical sta
bar equals 100 Am; top panel is shown at lower magnification than lower panels. S
Smo+/ cultures on the left, and lack of neuronal morphology of the few TuJ1-sta
Third panel on the left shows another example of TuJ1 staining of Smo+/ ce
morphology often displayed by TuJ1-positive fields (arrows). Third panel on the r
MAP2 staining was seen in Smo/ cultures. Bottom panel shows double staining
showing the radial glia-like morphology, TuJ1, RC2 and TuJ1 images overlain. TDiscussion
In the embryo, the nervous system is established by the
progressive commitment of pluripotential cell lineages. A
portion of the inner cell mass differentiates into primitive
ectoderm, the founding tissue for all three primary germ
layers. A subpopulation of the primitive ectoderm becomes
committed to definitive ectoderm, a subpopulation of which
becomes neurectoderm. A group of transcription factors
including Oct 3/4 (Rosner et al., 1990; Scholer et al.,
1990) and the recently identified Nanog (Chambers et al.,
2003; Mitsui et al., 2003) are involved in maintaining the
pluripotency and self-renewal properties of the inner cell
mass, primitive ectoderm, and ES cells. Less is understood
about how neurectoderm is established.
Our data and studies by others (Rathjen and Rathjen,
2001; Rathjen et al., 2002; Wichterle et al., 2002) suggest
that it is possible to mimic the steps from inner cell mass, to
ectoderm, to neurectoderm, in vitro, using ES cell embryoid
body culture. We show here that ES embryoid bodies express
ectoderm and neurectoderm markers as their cores cavitate to
produce a columnar epithelial cell layer. As noted by others
(Rathjen et al., 2001), the core cells do not exclusively
differentiate into neurectoderm under standard culture con-
ditions, but into a variety of ectodermal, mesodermal, and
definitive endodermal derivatives. We also demonstrate that
when Hedgehog signaling is absent or decreased, the extent
of neurectoderm differentiation is compromised. Careful
examination of the expression of a variety of markers is
consistent with arrest at the primitive ectoderm stage for
embryoid bodies derived from either Ihh/ or Smo/ ES
cells. Mutant cultures express the primitive ectoderm marker
FGF5, as well as modest levels of Otx2 and Sox2 mRNA,
two markers expressed in primitive ectoderm as well as in
neurectoderm. In contrast, levels of definitive neurectoderm
markers are dramatically down-regulated or absent in
cyclopamine-treated or mutant cultures. What exactly does
the Hedgehog signal promote in ES embryoid body cultures?
The block at the primitive ectoderm stage may be due to the
inability of the primitive ectoderm in these cultures to
cavitate, perhaps an essential step in the progression to
neurectoderm. Alternatively the block in neurectoderm
may be attributed to a Hedgehog requirement for either
establishing the neuronal lineages or promoting the prolif-
eration of neural progenitors, a role previously described foroid bodies formed from Smo+/ and Smo/ ES cells were scored for nestin
odies displayed a substantial amount (++ or +++) of nestin staining, whereas
ryoid bodies formed from Smo+/ and Smo/ ES cells were plated onto
and stained for nestin, TuJ1, MAP2, and RC2. Top panel shows typical
ining of Smo/ cultures, restricted to large, flat cells at the periphery. Scale
econd panel shows neuronal morphology of TuJ1-stained outgrowth cells in
ined Smo/ cells on the right. Matching phase contrast panels are shown.
lls, with the matching phase contrast panel showing the radial glia-like
ight, at higher magnification, shows MAP2 staining of Smo+/ cultures. No
of RC2 and TuJ1 in Smo+/ cultures. From left to right, RC2, phase contrast
here was no RC2 staining seen in Smo/ cultures.
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now examining these alternatives using the protocols for
generating neuronal cell types from ES cells that are de-
scribed below.
Our data suggest a role for Hedgehog signaling in
establishing neurectoderm. In contrast, a variety of in vivo
studies suggest that neurectoderm and a variety of neuronal
lineages are established normally in the absence of Hedge-
hog signaling. In zebrafish (Lewis and Eisen, 2001; Varga et
al., 2001) or mouse embryos (Zhang et al. 2001) that
completely lack Hedgehog signaling, there are defects in
CNS patterning and a loss of specific cell types, including
motor neurons, but other neuronal cell types are clearly
present. Recent analysis of the behavior of Smo/ cells in a
wild type background in chimeric embryos indicates that
mutant cells can participate in forming derivatives of the
dorsal but not the ventral spinal cord (Wijgerde et al., 2002).
The apparent absence of neurectoderm and neuronal differ-
entiation in cultures of ES cells deficient for Hedgehog
signaling is therefore a more severe phenotype than ob-
served in the embryo. This discrepancy could be attributable
to the presence of embryonic and/or maternal factors in
utero that are capable of promoting neurectoderm differen-
tiation, and are absent in vitro. The use of embryoid bodies
derived from ES cells carrying mutations in Hedgehog
cascade components should allow identification of such
factors based upon their ability to rescue, at least in part,
the neurectoderm phenotype described here.
Consistent with the inability to generate neurectoderm,
embryoid bodies derived from mutant ES cells are also
unable to produce neural derivatives. Several protocols have
been identified that promote or restrict differentiation of ES
cells into neural lineages. Most of these protocols rely upon
an embryoid body stage and therefore the production of
neurectoderm. The embryoid body-based protocol we have
employed uses retinoic acid to promote the generation of
neurons (Bain et al., 1995). Cultures derived from ES cells
heterozygous for either Ihh or Smo contain ample nestin-
positive cells as well as TuJ1 and MAP2-positive neurons.
In contrast, homozygous Ihh or Smo mutant cell lines
produce decreased numbers of nestin-positive neural pro-
genitors in comparison with heterozygous cell lines. The
nestin-positive cells present in homozygous mutant cultures
may not be neural stem cells. Nestin is expressed in multiple
cell types (Lendahl et al., 1990; Mokry and Nemecek,
1998), and our preliminary data indicating that the nestin-
positive cells in homozygous mutant cultures also express
a-smooth muscle actin, suggests they may be smooth
muscle cells. TuJ1 staining is also greatly reduced and never
found in cells with a neuronal morphology, and MAP2
staining is absent in mutant cultures. The heterozygous
cultures also contain radial glia, as defined by the marker
RC2, whereas homozygous mutant cultures do not. RC2-
positive cells are frequently found in regions of closely
aligned and elongated cells. In most instances, TuJ1-positive
neurons also localized to these domains or are foundelsewhere within the outgrowth of embryoid bodies that
contained these RC2-staining regions.
In addition to promoting subsequent neural differentia-
tion and increasing the levels of nestin and Sox1 expression,
we show here, as others have shown (Wichterle et al., 2002),
that retinoic acid treatment caudalizes neurectoderm derived
from ES cells, based upon the observed down-regulation of
anterior neurectoderm markers.
Protocols that selectively promote neuronal differentia-
tion from ES cells at the expense of other cell types,
resulting in relatively pure populations of neuronal deriv-
atives, have also been described. For example, it has been
demonstrated that ES cell embryoid body cores can differ-
entiate exclusively into a neurectoderm layer, at the ex-
pense of mesoderm or endoderm derivatives in the presence
of conditioned medium derived from the HepG2 liver cell
line (Rathjen et al., 2002). HepG2-conditioned medium
likely contains a subset of the signals secreted by the
visceral endoderm, a cell type similar to liver cells in terms
of the profile of protein expression (Dziadek and Andrews,
1983). This subset of signals is sufficient to induce differ-
entiation into ectoderm and neurectoderm derivatives, but
not into derivatives of the other germ layers. Our data
suggest that a Hedgehog peptide present in the HepG2-
conditioned medium is responsible for promoting neurec-
toderm differentiation.
The culture of embryoid bodies in a defined medium that
is 50% neurobasal medium (Gibco) also favors apparent
neurectoderm differentiation (Wichterle et al., 2002). Under
these conditions, Shh can induce the production of neural
cell types derived from the ventral neural tube, motor
neurons and interneurons, within ES embryoid bodies. In
this study, there is also no apparent endoderm layer on the
outer embryoid body surface, although this is not directly
examined, and therefore perhaps no source of Ihh. Thus, the
addition of an exogenous source of Hedgehog is required, in
addition to retinoic acid, to promote significant levels of
motor neuron differentiation. In addition to stimulating the
production of motor and interneurons, retinoic acid and
Hedgehog treatment also increases the number of cells
expressing the pan-neural markers NeuN and Sox1, sug-
gesting that a neural stem cell and not just a motor neuron
progenitor may be a target of treatment (Wichterle et al.,
2002).
An alternative protocol for promoting the differentiation
of ES cells into neurons also begins with embryoid body
formation, followed by culture in a serum-free defined
medium to select for neural stem cells, and then the
addition of growth factors to support their proliferation
(Lee et al., 2000; Okabe et al., 1996). The advantage of
this protocol is that it yields greatly enriched populations
of neural progenitors by selecting for these cells in defined
medium. The weakness of this approach is that it results in
high levels of cell death upon transfer of the cells to the
defined medium. Studies using this protocol suggest that
FGF2 and/or EGF are essential for neural stem cell
P. Maye et al. / Developmental Biology 265 (2004) 276–290 289proliferation; FGF8 and ascorbic acid increase the yield of
dopaminergic neurons; and BMPs inhibit neural differen-
tiation (Lee et al., 2000). Interestingly, Shh addition also
promotes production of dopaminergic neurons in this
protocol (Lee et al., 2000), while PDGF treatment appears
to increase the yield of glial cells (Brustle et al., 1999).
Our preliminary studies using this protocol suggest that ES
cells deficient in Hedgehog signaling are able to produce
few, if any, neural derivatives.
A modification of the protocols used for generating
neurons from mouse ES cells has been used to generate
enriched populations of neural progenitors derived from
human ES cells (Carpenter et al., 2001). Studies such as
ours, investigating the differentiation into neurons of mouse
ES cells carrying mutations in genes encoding signaling
molecules, will likely identify additional factors that can
promote, or inhibit, the generation of desired cell types in
these cultures. This information can be incorporated into the
human ES cell protocols and provide the groundwork for
defining conditions that will generate human ES cell deriv-
atives for transplantation therapies that can potentially treat
a variety of human neurological conditions.Acknowledgments
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